Pursuant to Regulation 7 (3) of SEBI (Listing Obligations and Disclosure requirements ) Regulations 2015, Sandu Pharmaceuticals has informed that it has complied with the requirements pursuant to Regulation 7 (2) of the said Regulations, by ensuring that all the activities in relation to both, Physical and Electronic, share transfer facilities Dematerlization and Rematerlization are maintained through its Registrar & Share Transfer Agent, Link Intime India, which is registered with the Board (SEBI), under Registration No. INR000004058 for the Half Year ended 30-09-2020.
The above information is a part of company’s filings submitted to BSE.
